Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
OneCell Diagnostics Inc. | $16,000,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Amplemarket
United States
- San Francisco, California
- 06/04/2022
- Series A
- $12,000,000
Amplemarket is the platform to help you sell in today's environment. From lead generation to personalized multichannel outreach and smart actions, Amplemarket improves your sales team’s performance and increases revenue!
Here's what you get:
- Data native: Easily find the data that helps you close deals
- Built-in personalization: 3x your response rates with hyper-personalized messages
- Multi-channel outreach: Email, Phone, LinkedIn, etc.
- AI-powered: Let reps focus on selling while AI takes care of the rest
- Industry Software Development
- Website https://amplemarket.com/
- LinkedIn https://www.linkedin.com/company/amplemarket/
Related People
Joao BatalhaCo Founder
United States -
San Francisco, California
Studied Computer Science & Engineering at MIT. Interested in physics, mathematics and computer science.
Founded Amplemarket with the premise that b2b sales teams should have one main system that manages the different sales flows that generate qualified meetings.
Co-founder of Fermat's Library, an annotation platform for scientific papers.
Enveda | $130,000,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Dote | $1,447,585 | (Nov 22, 2024)
CredFlow | $3,700,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)